Aspex Management (HK) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$198M |
| 2 |
GDS Holdings
GDS
|
+$157M |
| 3 |
TSP
TuSimple Holdings Inc. Class A Common Stock
TSP
|
+$91.3M |
| 4 |
YSG
Yatsen Holding
YSG
|
+$78.1M |
| 5 |
DDL
Dingdong
DDL
|
+$68.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$131M |
| 2 |
XPeng
XPEV
|
+$124M |
| 3 |
NIO
NIO
|
+$40.1M |
| 4 |
ZH
Zhihu
ZH
|
+$31.6M |
| 5 |
Qfin Holdings
QFIN
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 39.15% |
| 2 | Technology | 29.85% |
| 3 | Financials | 12.98% |
| 4 | Consumer Staples | 6.52% |
| 5 | Real Estate | 3.9% |
Similar funds
Aspex Management (HK)'s Q2 2021 Portfolio in Review
As of Q2 2021, Aspex Management (HK) held 28 positions worth $3.05B, up 21% from $2.53B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Aspex Management (HK) deployed $259M of net new capital in Q2 2021, opening 7 new positions and adding to 3 existing holdings. Its largest new stake was TuSimple Holdings Inc. Class A Common Stock: 2,121,626 shares worth $151M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, down from 46% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was XPeng, an estimated $124M trimmed.
- Aspex Management (HK)'s largest Q2 2021 buy was TuSimple Holdings Inc. Class A Common Stock: 2,121,626 shares worth $151M.
- Aspex Management (HK) added most to JD.com in Q2 2021, an estimated $198M increase.
- Aspex Management (HK)'s biggest Q2 2021 reduction was XPeng, cutting an estimated $124M.
- Aspex Management (HK) fully exited Pinduoduo in Q2 2021, selling an estimated $131M.
- Aspex Management (HK)'s ten largest holdings make up 82% of its $3.05B portfolio in Q2 2021.
- Aspex Management (HK) opened 7 new positions and closed 4 in Q2 2021.
- Aspex Management (HK)'s portfolio value rose 21% quarter-over-quarter to $3.05B.
Based on Aspex Management (HK)'s 13F filing for Q2 2021, filed 13 Aug 2021.